Cited by 157Hormonal and reproductive studiesFrailty in Older AdultsNutrition and Health in Aging

Sex Hormones and Frailty in Older Men: The Osteoporotic Fractures in Men (MrOS) Study

Open access
Cawthon, Peggy M., Ensrud, Kristine E., Laughlin, Gail A., Cauley, Jane A., Dam, Thuy-Tien L., Barrett-Connor, Elizabeth, Fink, Howard A., Hoffman, Andrew R. +6 more·2009·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: As men age, the prevalence of frailty increases whereas levels of androgens decline. Little is known about the relation between these factors. OBJECTIVE: The aim of this study was to assess cross-sectional and longitudinal associations of estradiol, bioavailable estradiol, testosterone, bioavailable testosterone (bioT), and SHBG with frailty status. DESIGN AND SETTING: The Osteoporotic Fractures in Men (MrOS) study was conducted at six U.S. clinical centers. PARTICIPANTS: A total of 1469 community-dwelling men at least 65 yr old with baseline data participated; 1245 men had frailty status reassessed 4.1 yr later. MAIN OUTCOME MEASURE: Proportional odds models estimated the likelihood of greater frailty status. Frail men had at least three of the following: weakness, slowness, low activity, exhaustion, and shrinking/sarcopenia; intermediate men had one or two criteria; and robust men had none. At follow-up, death was included as an additional ordinal outcome. Sex hormones were assayed by spectrometry/chromatographic methods. RESULTS: In cross-sectional analyses, men in the lowest quartile of bioT had 1.39-fold (95% confidence interval, 1.02, 1.91) increased odds of greater frailty status compared to men in the highest quartile after adjustment for covariates including age, body size, health status, and medical conditions. In age-adjusted longitudinal analyses, men in the lowest quartile of bioT had 1.51-fold (95% confidence interval, 1.10, 2.07) increased odds of greater frailty status 4.1 yr later. This association was largely attenuated by adjustment for covariates. No other hormones were associated in a cross-sectional or longitudinal manner with frailty status after adjustment. CONCLUSIONS: Low levels of bioT were independently associated with worse baseline frailty status. Frailty status should be considered as an outcome in trials of testosterone supplementation.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-0417

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cawthon, P. M., Ensrud, K. E., Laughlin, G. A., Cauley, J. A., Dam, T.-T. L., Barrett-Connor, E., Fink, H. A., Hoffman, A. R., Lau, E., Lane, N. E., Stefanick, M. L., Cummings, S. R., Orwoll, E. S., & for the Osteoporotic Fractures in Men (MrOS) Research Group
Affiliations
  • California Pacific Medical Center (US)
  • University of Minnesota (US)
  • University of California San Diego (US)
  • University of Pittsburgh (US)
  • Columbia University (US)
  • VA Palo Alto Health Care System (US)
  • Center for Health and Medical Research (E.L.), Hong Kong, China
  • University of California Davis Medical Center (US)
  • Stanford Medicine (US)
  • Oregon Health & Science University (US)
Corresponding author
Cawthon, Peggy M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-10-01
Volume
94
Issue
10
Pages
3806-3815
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2096777479
Cited by
157
References
5
Citations by year
2026: 4 · 2025: 7 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 12 · 2016: 11 · 2015: 9 · 2014: 8 · 2013: 12 · 2012: 12
FWCI
11.17
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (U01-AG-18197, U01AG018197, U01AG027810, U01AG042140)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR45614, U01-AR45632, U01 AR45647, U01AR045583, U01 AR-45583, U01-AR-45654, U01AR045580, U01AR045632, U01AR045654, K24AR048841, U01AR045614, U01AR045647, U01AR066160, U01AR45580)
  • National Center for Research Resources (UL1RR024140)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
frailty, sex hormones, testosterone, bioavailable testosterone, estradiol, sex hormone-binding globulin, older men, androgen decline, sarcopenia, mortality, testosterone supplementation, MrOS study
MeSH terms
Aged, Aged, 80 and over, Biological Availability, Cross-Sectional Studies, Estradiol, Follow-Up Studies, Fractures, Spontaneous, Humans, Male, Osteoporosis, Residence Characteristics, Sex Hormone-Binding Globulin, Testosterone, Absorptiometry, Photon, Prevalence, Odds Ratio, Frail Elderly, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review